We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+9.3%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$282M
AUM Growth
+$52.2M
Cap. Flow
+$37.1M
Cap. Flow %
13.15%
Top 10 Hldgs %
53.18%
Holding
123
New
20
Increased
19
Reduced
30
Closed
30

Top Buys

Rank Stock Value
1
GDX icon
VanEck Gold Miners ETF
GDX
+$2.1M
2
ALT icon
Altimmune
ALT
+$1.99M
3
PFE icon
Pfizer
PFE
+$1.94M
4
PSFE icon
Paysafe
PSFE
+$1.38M
5
F icon
Ford
F
+$1.2M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$3.33M
2
ABBV icon
AbbVie
ABBV
+$2.82M
3
T icon
AT&T
T
+$1.96M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$1.83M
5
GLD icon
SPDR Gold Trust
GLD
+$1.7M

Sector Composition

Rank Sector Weight
1 Healthcare 28.83%
2 Technology 11.75%
3 Communication Services 8.8%
4 Financials 4.55%
5 Consumer Discretionary 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$61.4M 21.76%
+143,500
New +$59.9M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.36T
$16.3M 5.77%
130,000
– –
ITCI
3
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$15.3M 5.42%
375,000
-49,500
-12% -$1.83M
MU icon
4
Micron Technology
MU
$930B
$14.4M 5.12%
170,000
+10,000
+6% +$844K
ABBV icon
5
AbbVie
ABBV
$443B
$8.67M 3.07%
77,000
-25,000
-25% -$2.82M
REGN icon
6
Regeneron Pharmaceuticals
REGN
$78.5B
$8.66M 3.07%
15,500
+2,000
+15% +$1.01M
XNCR icon
7
Xencor
XNCR
$1.5B
$6.79M 2.41%
197,000
+7,000
+4% +$278K
GDX icon
8
VanEck Gold Miners ETF
GDX
$22.7B
$6.29M 2.23%
185,000
+57,500
+45% +$2.1M
BAC icon
9
Bank of America
BAC
$435B
$6.18M 2.19%
150,000
– –
ARGX icon
10
argenx
ARGX
$53.4B
$6.02M 2.13%
20,000
-4,000
-17% -$1.14M
GM icon
11
General Motors
GM
$80.4B
$5.92M 2.1%
100,000
– –
VZ icon
12
Verizon
VZ
$195B
$5.6M 1.99%
100,000
+12,500
+14% +$717K
TPB icon
13
Turning Point Brands
TPB
$1.45B
$5.59M 1.98%
122,250
– –
GLD icon
14
SPDR Gold Trust
GLD
$131B
$5.38M 1.91%
32,500
-10,000
-24% -$1.7M
AMD icon
15
Advanced Micro Devices
AMD
$776B
$5.17M 1.83%
55,000
– –
INCY icon
16
Incyte
INCY
$24.2B
$5.13M 1.82%
61,000
-4,000
-6% -$334K
ORCL icon
17
Oracle
ORCL
$374B
$4.87M 1.72%
62,500
-42,500
-40% -$3.33M
C icon
18
Citigroup
C
$222B
$4.6M 1.63%
65,000
– –
QQQ icon
19
CALL
Invesco QQQ Trust
QQQ
$453B
$4.43M 1.57%
12,500
+2,500
+25% +$841K
AMZN icon
20
CALL
Amazon
AMZN
$2.92T
$3.78M 1.34%
+22,000
New +$3.66M
IAU icon
21
iShares Gold Trust
IAU
$62.9B
$3.37M 1.19%
100,000
– –
KIN
22
DELISTED
Kindred Biosciences, Inc.
KIN
$3.32M 1.18%
362,315
+161,315
+80% +$938K
GLD icon
23
PUT
SPDR Gold Trust
GLD
$131B
$3.31M 1.17%
+20,000
New +$3.4M
PRTA icon
24
Prothena Corp
PRTA
$425M
$3.17M 1.13%
61,750
+15,894
+35% +$496K
ALNY icon
25
Alnylam Pharmaceuticals
ALNY
$27.5B
$2.97M 1.05%
17,500
-2,500
-13% -$366K
1
2 3 4 5

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, DCF Advisers held 123 positions worth $282M, up 23% from $230M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

DCF Advisers deployed $37.1M of net new capital in Q2 2021, opening 20 new positions and adding to 19 existing holdings. Its largest new stake was Altimmune: 145,750 shares worth $1.44M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Oracle, an estimated $3.33M trimmed.

  • DCF Advisers's largest Q2 2021 buy was Altimmune: 145,750 shares worth $1.44M.
  • DCF Advisers added most to VanEck Gold Miners ETF in Q2 2021, an estimated $2.1M increase.
  • DCF Advisers's biggest Q2 2021 reduction was Oracle, cutting an estimated $3.33M.
  • DCF Advisers fully exited CVS Health in Q2 2021, selling an estimated $1.62M.
  • DCF Advisers's ten largest holdings make up 53% of its $282M portfolio in Q2 2021.
  • DCF Advisers opened 20 new positions and closed 30 in Q2 2021.
  • DCF Advisers's portfolio value rose 23% quarter-over-quarter to $282M.

Based on DCF Advisers's 13F filing for Q2 2021, filed 13 Aug 2021.